Cargando…

Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer

Detalles Bibliográficos
Autores principales:	Nadesh, Ragima, Menon, Krishnakumar N., Biswas, Lalitha, Mony, Ullas, Subramania Iyer, K., Vijayaraghavan, Sundeep, Nambiar, Ajit, Nair, Shantikumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328926/ https://www.ncbi.nlm.nih.gov/pubmed/37420005 http://dx.doi.org/10.1038/s41598-023-38226-2

Ejemplares similares

Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer
por: Nadesh, Ragima, et al.
Publicado: (2021)

Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells
por: Nair, Maya S, et al.
Publicado: (2015)

Author Correction: CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

Unexplored Excipients in Biotherapeutic Formulations: Natural Osmolytes as Potential Stabilizers Against Thermally Induced Aggregation of IgG1 Biotherapeutics
por: Bhojane, Purva P., et al.
Publicado: (2021)

Computational models for studying physical instabilities in high concentration biotherapeutic formulations
por: Blanco, Marco A.
Publicado: (2022)

Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
por: Kuriakose, Anshu, et al.
Publicado: (2016)

Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development
por: Sauna, Zuben E., et al.
Publicado: (2023)

Maxillary reconstruction: Current concepts and controversies
por: Iyer, Subramania, et al.
Publicado: (2014)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023)

Author Correction: Shotgun proteomics reveals putative polyesterases in the secretome of the rock-inhabiting fungus Knufia chersonesos
por: Tesei, Donatella, et al.
Publicado: (2020)

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target
por: Han, Suji, et al.
Publicado: (2020)

First two bilateral hand transplantations in India (Part 4): Immediate post-operative care, immunosuppression protocol and monitoring
por: Iyer, Subramania, et al.
Publicado: (2017)

Cross-chest liposuction in gynaecomastia
por: Murali, Biju, et al.
Publicado: (2011)

In vivo selection of novel biotherapeutics
por: Ruozi, Giulia, et al.
Publicado: (2015)

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
por: Jefferis, Roy
Publicado: (2016)

The Development Pathway for Biosimilar Biotherapeutics
por: Zarbin, Marco
Publicado: (2020)

The Emerging Biotherapeutic Agent: Akkermansia
por: Kalia, Vipin Chandra, et al.
Publicado: (2021)

Editorial: Characterization of biotherapeutic products
por: Rathore, Anurag S., et al.
Publicado: (2022)

Evaluation of Antigenicity of Components of Tracheal Allotransplant and Effect of Immunosuppressant Regime in a Rodent Model
por: Sharma, Dimpy, et al.
Publicado: (2020)

Hydrogen/deuterium exchange-mass spectrometry analysis of high concentration biotherapeutics: application to phase-separated antibody formulations
por: Tian, Yuwei, et al.
Publicado: (2019)

Pediatric Dosing and Body Size in Biotherapeutics
por: Shi, Rong, et al.
Publicado: (2010)

Regulatory Pathway for Licensing Biotherapeutics in Mexico
por: López-Morales, Carlos A., et al.
Publicado: (2018)

Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
por: Husain, Bushra, et al.
Publicado: (2018)

Cyanobacterial Production of Biopharmaceutical and Biotherapeutic Proteins
por: Betterle, Nico, et al.
Publicado: (2020)

IgY Antibodies as Biotherapeutics in Biomedicine
por: León-Núñez, Diana, et al.
Publicado: (2022)

Interactome based identification and validation of prefoldin 5-α for prognosing CNS leukemia in B-ALL patients
por: Xavier, Tessy, et al.
Publicado: (2022)

Potentials and limitations of microorganisms as renal failure biotherapeutics
por: Jain, Poonam, et al.
Publicado: (2009)

Antibiotic-Free Selection in Biotherapeutics: Now and Forever
por: Mignon, Charlotte, et al.
Publicado: (2015)

Response regarding Colombian regulation of biotherapeutic products
por: Vaca, Claudia, et al.
Publicado: (2017)

Engineering Components of the Lactobacillus S-Layer for Biotherapeutic Applications
por: Klotz, Courtney, et al.
Publicado: (2018)

Editorial: Synthetic Live Biotherapeutic Products for Diseases
por: Chen, Ye, et al.
Publicado: (2022)

Ferritin – a multifaceted protein scaffold for biotherapeutics
por: Lee, Na Kyeong, et al.
Publicado: (2022)

Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential
por: McHenry, Peter R., et al.
Publicado: (2023)

Effect of external volume expansion on the survival of fat grafts
por: Reddy, Raghuveer, et al.
Publicado: (2016)

Flap Hitching Technique to the Teeth after Oral Cancer Resection
por: Thankappan, Krishnakumar, et al.
Publicado: (2012)

Soft embalming of cadavers for training purposes: Optimising for long-term use in tropical weather
por: Reddy, Raghuveer, et al.
Publicado: (2017)

Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
por: Kumar, Manoj, et al.
Publicado: (2012)

Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates
por: Hong, Paula, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uqo3l0c2t6ru1mjqna9cbe12nl